Hardest OCN Practice Questions — Can You Answer These?

In 2026, CRC incidence is increasing by approximately 1-2% annually in adults under 50, while it is decreasing in older adults (65+) due to high screening uptake. Clinical Pearl: This trend led to the guideline change lowering the screening start age to 45 for average-risk individuals. Exam Strategy: Be prepared to identify that younger patients often present with more advanced (Stage III/IV) disease at diagnosis because symptoms are often dismissed as benign (e.g., hemorrhoids). Additionally, rectal cancer is rising faster than colon cancer in the under-50 demographic.

Hepatocellular Carcinoma (HCC) incidence is increasingly driven by MASLD (formerly NAFLD) and obesity, rather than just Hepatitis B or C. Rational: While antiviral therapies have reduced viral-related HCC, the metabolic syndrome epidemic has shifted the etiology. Clinical Pearl: Liver cancer incidence has risen faster than almost any other cancer in the last two decades. Exam Tip: ONCC focuses on modifiable risk factors; obesity is now linked to at least 13 different types of cancer, with liver and endometrial showing the strongest correlations.

In 2026, the annual number of HPV-associated oropharyngeal cancers (primarily in men) significantly exceeds the number of HPV-associated cervical cancers. Rational: Effective Pap/HPV screening and vaccination have reduced cervical cancer incidence, whereas there is no standard screening for oropharyngeal cancer. Exam Tip: Note that HPV-16 is the most common high-risk strain associated with both. Prevention via the 9-valent HPV vaccine is most effective when administered before age 15 but is recommended up to age 26 (and shared decision making up to 45).

Breast Cancer. While overall mortality is down, there is a concerning trend of increased distant-stage (metastatic) diagnoses at initial presentation. Black women are 40% more likely to die from breast cancer than White women and are more likely to be diagnosed with Triple-Negative Breast Cancer (TNBC). Rational: This reflects disparities in screening quality, follow-up, and biological aggressiveness. Exam Strategy: Look for Triple-Negative as a keyword for poorer prognosis and distinct epidemiological patterns in younger Black women.

Endometrial Cancer (Uterine Corpus). It is one of the few cancers where both incidence and mortality are increasing in the US. Rational: This is heavily linked to the rising rates of Class III obesity and metabolic syndrome, which create a state of chronic hyperestrogenism. Exam Tip: Endometrial cancer was historically seen in post-menopausal women, but OCN candidates must recognize the shifting trend toward younger, obese pre-menopausal patients. Mortality is also rising faster in Black women, who are more likely to have aggressive non-endometrioid subtypes.